HunnerG.Elusive ulcer of the bladder: Further notes on a rare type of bladder ulcer with reports of 25 cases.Am J Obstet1918; 78: 374–395.
2.
Van De MerweJ, NordlingJ, BoucheloucheK.Diagnostic criteria, classification and nomenclature for painful bladder syndrome/interstitial cystitis: An ESSIC proposal.Eur Urol2008; 53: 60–67.
3.
HannoPM, BurksDA, ClemensJQ.AUA guidelines for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome.J Urol2011; 185: 2162–2170.
4.
PeekerR, and FallM.Towards a precise definition of interstitial cystitis: Further evidence of differences in classis and nonulcer disease.J Urol2002; 167: 2470–2472.
5.
LogadottirY, FallM, Kabjorn-GustafssonC.Clinical characteristics differ considerable between phenotypes of bladder pain syndrome/interstitial cystitis.Scand J Nephrol2012; 46: 365–370.
6.
KillingerKA, BouraJA, and PetersKM.Pain in interstitial cystitis/bladder pain syndrome: Do characteristics differ in ulcerative and non-ulcerative subtypes?Int Urogynecol J2013; 24: 1295–1301.
7.
NickelJC, ShoskesD, and Irvine-BirdK.Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: A key to classification and potentially improved management.J Urol2009; 182: 155–160.
8.
TrippDA, NickelJC, WongJ.Mapping of pain phenotypes in female patients with bladder pain syndrome/interstitial cystitis and controls.Eur Urol2012; 62: 1188–1194.
9.
AlagiriM, ChottinerS, RatnerV.Interstitial cystitis: Unexplained associations with other chronic diseases and pain syndromes.Urology1997; 49: 52–57.
10.
CarricoDJ, ShererKL, and PetersKM.The relationship of interstitial cystitis/painful bladder syndrome to vulvodynia.Urol Nurs2009; 29: 233–238.
11.
TirlapurSA, KuhrtK, ChalihaC.The ‘evil twin syndrome’ in chronic pelvic pain: A systematic review of prevalence studies of bladder pain syndrome and endometriosis.In J Surg2013; 11: 233–237.
12.
HoltonKF, KindlerLL, and JonesKD.Potential dietary links to central sensitization in fibromyalgia: Past reports and future directions.Rheum Dis Clin North Am2009; 35: 409–420.
13.
NickelJC, TrippDA, PontariM.Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome.J Urol2010; 184: 1358–1363.
14.
van de MerweJP, YamadaT, and SakamotoY.Systemic aspects of interstitial cystitis, immunology and linkage with autoimmune disorders.Int J Urol2003; 10: S35–S38.
15.
NigroDA, WeinAJ, FoyM.Associations amongst cystoscopic and urodynamic findings in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study.Urology1997; 49 (5A Suppl): 86–92.
16.
PetersKM, KalinowskiSE, CarricoDJ.Fact or fiction - is abuse prevalent in patients with interstitial cystitis? Results from a community survey and clinic population.J Urol2007; 178: 891–895.
17.
KellerJJ, ChenYK, and LinHC.Comorbidities of bladder pain syndrome/interstitial cystitis: A population-based study.BJU Int2012; 110: E903–E909.
18.
KellerJ, ChenYK, and LinHC.Association of bladder pain syndrome/interstitial cystitis with urinary calculus: A nationwide population-based study.Int Urogynecol J2013; 24: 565–571.
19.
KellerJ, ChiouHY, and LinHC.Increased risk of bladder cancer following diagnosis with bladder pain syndrome/interstitial cystitis.Neurourol Urodyn2013; 32: 58–62.
20.
SuskindAM, BerrySH, EwingBA.The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: Results of the RAND Interstitial Cystitis Epidemiology Male Study.J Urol2013; 189: 141–145.
21.
ChungSD, KellerJ, and LinHC.A nationwide population-based study on bladder pain syndrome/interstitial cystitis and ED.Int J Impot Res2013; doi:10.1038/ijir.2013.15 [Epub ahead of print].
22.
HannoP, LinA, NordlingJ.Bladder Pain Syndrome International Consultation on Incontinence.Neurourol Urodyn2010; 29: 191–198.
23.
WarrenJW, JacksonTL, LangenbergP.Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis.Urology2004; 63: 17–21.
24.
PeekerR, EnerbäckL, FallM.Recruitment, distribution and phenotypes of mast cells in interstitial cystitis.J Urol2000; 163: 1009–1015.
25.
ParsonsCL, LillyJD, and SteinP.Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis).J Urol1991; 145: 732–735.
26.
YilmazU, LiuYW, BergerRE.Autonomic nervous system changes in men with chronic pelvic pain syndrome.J Urol2007; 177: 2170–2174.
27.
GamperM, ViereckV, EberhardJ.Local immune response in bladder pain syndrome/interstitial cystitis ESSIC type 3C.Int Urogynecol J2013 [Epub ahead of print] DOI 10.1007/s00192-013-2112-0
28.
KiuchiH, TsujimuraA, TakaoT.Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: its association with pain severity and glomerulations.BJU Int2009; 104: 826–31.
29.
LeeJD, and LeeMH.Increased expression of hypoxiainducible factor-1 and vascular endothelial growth factor associated with glomerulation formation in patients with interstitial cystitis.Urology2011; 78: 971.e11-15.
30.
PontariMA, HannoPM, and RuggieriMR.Comparison of bladder blood flow in patients with and without interstitial cystitis.J Urol1999; 162: 330–334.
31.
ZhangCO, WangJY, KochKR.Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis.J Urol2005; 174: 2382–2387.
32.
KeayS, ZhangCO, HiseMK.A diagnostic in vitro urine assay for interstitial cystitis.Urology1998; 52: 974–978.
33.
KeaySK, ZhangCO, ShoenfeltJ.Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis.Urology2001; 57 (6 Suppl 1): 9–14.
34.
ChaiTC, ZhangCO, ShoenfeltJL.Bladder stretch alters urinary heparin-binding epidermal growth factor and antiproliferative factor in patients with interstitial cystitis.J Urol2000; 163: 1440–1444.
35.
BirderLA, Wolf-JohnstonA, ChibM.Beyond neurons: involvement of urothelial and glial cells in bladder function.Neurourol Urodyn2013; 29: 88–96.
36.
LuiHT, TyagiP, ChancellorMB.Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.BJU Int2009; 104: 1476–1481.
37.
DahaLK, RiedlCR, HohlbruggerG.Comparative assessment of maximal bladder capacity, 0.9% NaCL versus 0.2M KCl, for the diagnosis of interstitial cystitis: a prospective controlled study.J Urol2003; 170: 807–809.
38.
ShorterB, LesserM, MoldwinR.Effects of comestibles on symptoms of interstitial cystitis.J Urol2007; 178: 145–152.
39.
Van OphovenA, PokupicS, HeineckeA.A prospective, randomised, placebo controlled, double blind study of amitriptyline for the treatment of interstitial cystitis.J Urol2004; 172: 533–536.
40.
Van OphovenA, and HertleL.Long-term results of amitriptyline treatment for interstitial cystitis.J Urol2005; 174: 1837–1840.
41.
FosterHE, HannoPM, NickelJC.Interstitial Cystitis Collaborative Research Network. Effect of amitriptyline on symptoms in treatment naive patients with interstitial cystitis/painful bladder syndrome.J Urol2010; 183: 1853–1858.
42.
NickelJC, BarkinJ, ForrestJ.Elmiron Study Group. Randomised, double blind-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis.Urology2005; 65: 654–658.
43.
HannoPM.Analysis of longterm Elmiron therapy for interstitial cystitis.Urology1997; 49 (5A Suppl): 93–99.
44.
TheoharidesTC.Hydroxyzine for interstitial cystitis.Urol Clin North Am1994; 21: 113–119.
45.
LeeJ, HanD, and JeongH.Bladder pain syndrome treated with triple therapy with gabapentin, amitriptyline and a non-steroidal anti-inflammatory drug.Int Neurourol J2010; 14: 256–260.
46.
Perez-MarreroR, EmersonLE, and FeltisJT.A controlled study of dimethyl sulfoxide in interstitial cystitis.J Urol1988; 140: 36–39.
47.
NickelJC, MoldwinR, LeeS.Intravesical alkalinised lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome.BJU Int2009; 103: 910–918.
48.
ParsonsCL.Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis.Urology2005; 65: 45–48.
49.
ParsonsCL, HousleyT, SchmidJD.Treatment of interstitial cystitis with intravesical heparin.Br J Urol1994; 73: 504–507.
50.
KuoHC.Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis.J Formos Med Assoc2001; 100: 309–314.
51.
MoralesA, EmersonL, NickelJC.Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis.Urology1997; 49 (5A Suppl): 111–113.
52.
EngelhardtPF, MorakisN, DahaLK.Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis.Int Urogynecol J Pelvic Floor Dysfunct2011; 22: 401–405.
53.
NickelJC, HannoP, KumarK.Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulphate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.Urology2012; 79: 1220–1224.
54.
GibertiC, GalloF, CorteseP.Combined intravesical sodium hyaluronate/chondroitin sulphate therapy for interstitial cystitis/bladder pain syndrome: A prospective study.Ther Adv Urol2013; 5: 175–179.
55.
CervigniM, NataleF, NastaL.Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome/interstitial cystitis: Long-term treatment results.Int Urogynecol J2012; 23: 1187–1192.
56.
BadeJJ, LaseurM, NieuwenburgA.A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis.Br J Urol1997; 79: 168–171.
57.
DahaLK, LazarD, SimakR.The effects of intravesical pentosanpolysulfate treatment on the symptoms of patients with bladder pain syndrome/interstitial cystitis: Preliminary results.Int Urogynecol J Pelvic Floor Dysfunct2008; 19: 987–990.
58.
RosamiliaA, DwyerPL, and GibsonJ.Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis.Int Urogynecol J Pelvic Floor Dysfunct1997; 8: 142–145.
59.
RiedlCR, KnollM, PlasE.Electromotive drug administration and hydrodistension for the treatment of interstitial cystitis.J Endourol1998; 12: 269–272.
60.
PeekerR, AldenborgF, and FallM.Complete transurethral resection of ulcers in classic interstitial cystitis.Int Urogynecol J Pelvic Floor Dysfunct2000; 11: 290–295.
61.
OttemDP, and TeichmanJM.What is the value of cystoscopy with hydrodistension for interstitial cystitis?Urology2005; 66: 494–499.
62.
GajewskiJB, and Al-ZahraniAA.The longterm efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre.BJU Int2011; 107: 1258–1264.
63.
KuoHC, and ChancellorMB.Comparison of intravesical botulinum toxin type A injections plus hydrodistension alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.BJU Int2009; 104: 657–661.
64.
PintoR, LopesT, SilvaC.Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.J Urol2013; 189: 548–553.
65.
SairanenJ, TammelaTL, LeppilahtiM.Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: A randomised comparative study.J Urol2005; 174: 2235–2238.
66.
ForrestJB, PayneCK, and EricksonDR.Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: Experience of 3 tertiary centers.J Urol2012; 188: 1186–1191.
67.
GiannantoniA, BiniV, DmochowskiR.Contemporary management of the painful bladder: A systematic review.Eur Urol2012; 61: 29–53.
68.
RossbergerJ, FallM, JonssonO.Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: Subtyping is imperative.Urology2007; 70: 638–642.
69.
Van OphovenA, OberpenningF, and HertleL.Longterm results of trigone-preserving orthotopic substitution enterocystoplasty for interstitial cystitis.J Urol2002; 167: 603–607.
70.
KochakarnW, LertsithichaiP, and PummanguraW.Bladder substitution by ileal neobladder for women with interstitial cystitis.International Braz J Urol2007; 33: 486–492.
71.
JeongHJ.Effects of a short course of oral prednisolone in patients with bladder pain syndrome with fluctuating, worsening pain despite low-dose triple therapy.Int Neurourol J2012; 16: 175–180.
72.
UedaT, TamakiM, OgawaO.Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T.J Urol2000; 164: 1917–1920.
73.
TheoharidesTC, and SantGR.A pilot open label study of Cystoprotek in interstitial cystitis.Int J Immunopathol Pharmacol2005; 18: 183–188.
74.
van OphovenA, RossbachG, PajonkF.Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: A randomised, sham controlled, double-blind trial.J Urol2006; 176: 1442–1446.
75.
TanakaT, NittaY, MorimotoK.Hyperbaric oxygen therapy for painful bladder syndrome/interstitial cystitis resistant to conventional treatments: Long-term results of a case series in Japan.BMC Urol2011; 11–16.
76.
Gallego-VilarD, Garcia-FadriqueG, Povo-MartinI.Maintenance of the response to dimethyl sulfoxide treatment using hyperbaric oxygen in interstitial cystitis/painful bladder syndrome: A prospective, randomized, comparative study.Urol Int2013; 90: 411–416.
77.
EvansRJ, MoldwinRM, CossonsN.Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis.J Urol2011; 185: 1716–1721.
78.
NickelJC, JainP, ShoreN.Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: Safety and efficacy of a new drug delivery device.Sci Transl Med2012; 4: 143ra100.
79.
HsuCC, ChuangYC, and ChancellorMB.Intravesical drug delivery for dysfunctional bladder.Int J Urol2013; 20: 552–562.
